Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
PureCycle Technologies	PCT	18. nov 2024	11.60	+5.07
PureCycle Technologies Unit	PCTTU	18. nov 2024	15.43	-3.74
Purefunds ISE Junior Silver [Sm	SILJ	18. nov 2024	12.17	+3.75
PureTech Health ADR	PRTC	18. nov 2024	21.55	-5.57
Purple Biotech ADR	PPBT	18. nov 2024	2.55	+1.80
Purple Innovation	PRPL	18. nov 2024	0.82	-0.29
Putnam Managed Municipal Income Trust	PMM	18. nov 2024	6.21	+0.24
Putnam Master Intermediate Income Trust	PIM	18. nov 2024	3.23	+0.47
Putnam Municipal Opportunities Trust	PMO	18. nov 2024	10.50	+0.65
Putnam Premier Income Trust	PPT	18. nov 2024	3.52	+0.57
PVH	PVH	18. nov 2024	100.83	-1.23
Pyrophyte Acquisition	PHYT	18. nov 2024	11.55	0.00
Pyxis Oncology	PYXS	18. nov 2024	4.09	-2.39
Pyxis Tankers	PXS	18. nov 2024	4.16	+3.23
Pyxis Tankers Pref	PXSAP	18. nov 2024	24.97	0.00
Q2	QTWO	18. nov 2024	96.38	-0.76
Q32 Bio	QTTB	18. nov 2024	31.41	-4.67
QCR	QCRH	18. nov 2024	88.91	-1.09
QIAGEN	QGEN	18. nov 2024	40.99	-0.68
Qifu Technology ADR	QFIN	18. nov 2024	32.27	+4.98
QMMM	QMMM	18. nov 2024	1.73	-76.40
Qomolangma Acquisition	QOMO	18. nov 2024	11.55	0.00
Qorvo	QRVO	18. nov 2024	66.32	+1.08
QT Imaging	QTI	18. nov 2024	0.51	-10.37
Quad Graphics A	QUAD	18. nov 2024	7.07	-0.28
Quaker Houghton	KWR	18. nov 2024	167.14	-0.34
QUALCOMM	QCOM	18. nov 2024	164.50	+2.49
Qualigen Therapeutics	QLGN	18. nov 2024	3.64	+1.11
Qualys	QLYS	18. nov 2024	143.86	-1.14
Quanex Building Products	NX	18. nov 2024	30.05	+0.33

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.